Dalfampridine for Imbalance in Multiple Sclerosis

NCT01444300 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Fatigue

Interventions

DRUG: Dalfampridine
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]